INFQ
Quantum, but make it discounted
Wedbush Securities jumped into the Infleqtion story with a pretty spicy opener: the firm says the stock is “meaningfully mispriced” and slapped on an Outperform rating plus a $20 price target. That implies about 25% upside from where the shares were trading, which is Wall Street-speak for: “We think this thing is still on sale.”
Why Wedbush thinks the market is missing the plot
The analysts argued that Infleqtion is getting less love than it deserves for a few reasons:
- neutral atoms still feel unproven to a lot of investors compared with rival quantum approaches
- the market may be pigeonholing INFQ as a sensing play instead of a full-stack quantum company
- the stock only started trading in February, so it’s still relatively thin, illiquid, and under-covered
Their bigger point? In a field where nobody has crowned a winner yet, Infleqtion may be one of the cleaner ways to get exposure without trying to pick the eventual quantum champion like it’s the final rose on a dating show.
Washington just added some jet fuel
The timing helps too. President Trump signed an executive order on June 22 aimed at speeding up quantum technologies for national security, commercial, and scientific use cases, and Infleqtion CEO Matthew Kinsella was at the White House for the signing. The company also previously landed $100 million in Department of Commerce funding tied to large-scale neutral-atom quantum systems.
That doesn’t mean the stock gets a free pass to the moon. But it does mean the policy backdrop is turning more supportive right when analysts are trying to convince the market this isn’t just a science project with a ticker.
Big picture
Infleqtion reported Q1 2026 revenue of $9.5 million, up 14% year over year, and reaffirmed full-year revenue guidance of at least $40 million. So the company is still early, still small, and still very much in the “promise more than proof” phase — but in quantum land, that’s kind of the whole game.
Big picture: Wedbush just gave INFQ a louder megaphone, and with policy support building, the stock may get a fresh round of investor attention before the quantum thesis stops being futuristic and starts being portfolio-worthy.